Nathan Lo

Nathan Lo

University of California, San Francisco

H-index: 27

North America-United States

About Nathan Lo

Nathan Lo, With an exceptional h-index of 27 and a recent h-index of 25 (since 2020), a distinguished researcher at University of California, San Francisco,

His recent articles reflect a diverse array of research interests and contributions to the field:

Cost-effectiveness and public health impact of typhoid conjugate vaccine introduction strategies in Bangladesh

Comparing frequency of booster vaccination to prevent severe COVID-19 by risk group in the United States

Development of prediction models to identify hotspots of schistosomiasis in endemic regions to guide mass drug administration

Cost-effectiveness of mass drug administration with ivermectin against strongyloidiasis: a modelling study

Determining herd immunity thresholds for hepatitis A virus transmission to inform vaccination strategies among people who inject drugs in 16 US States

Predicting the Public Health Impact of Bivalent Vaccines and Nirmatrelvir-Ritonavir Against Coronavirus Disease 2019

Outbreaks in US Migrant Detention Centers-A Vaccine-Preventable Cause of Health Inequity

Public health impact and cost-effectiveness of screening for active tuberculosis disease or infection among children in South Africa

Nathan Lo Information

University

Position

(UCSF)

Citations(all)

3538

Citations(since 2020)

3213

Cited By

1463

hIndex(all)

27

hIndex(since 2020)

25

i10Index(all)

43

i10Index(since 2020)

38

Email

University Profile Page

Google Scholar

Top articles of Nathan Lo

Cost-effectiveness and public health impact of typhoid conjugate vaccine introduction strategies in Bangladesh

Vaccine

2024/3/25

Comparing frequency of booster vaccination to prevent severe COVID-19 by risk group in the United States

Nature Communications

2024/3/6

Development of prediction models to identify hotspots of schistosomiasis in endemic regions to guide mass drug administration

Proceedings of the National Academy of Sciences

2024/1/9

Cost-effectiveness of mass drug administration with ivermectin against strongyloidiasis: a modelling study

medRxiv

2024

Determining herd immunity thresholds for hepatitis A virus transmission to inform vaccination strategies among people who inject drugs in 16 US States

Clinical Infectious Diseases

2023/9/21

Predicting the Public Health Impact of Bivalent Vaccines and Nirmatrelvir-Ritonavir Against Coronavirus Disease 2019

Open Forum Infectious Diseases

2023/9

Outbreaks in US Migrant Detention Centers-A Vaccine-Preventable Cause of Health Inequity

New England Journal of Medicine

2023/8/24

Public health impact and cost-effectiveness of screening for active tuberculosis disease or infection among children in South Africa

Clinical Infectious Diseases

2023/12/1

A sustainable way to control the parasitic disease schistosomiasis

2023/7/27

Perspective on schistosomiasis drug discovery: highlights from a schistosomiasis drug discovery workshop at Wellcome Collection, London, September 2022

2023/4/21

Burden of typhoid and paratyphoid fever in India

New England Journal of Medicine

2023/4/20

Evaluation of the US Definitions for Coronavirus Disease 2019 Community Risk Levels

Clinical Infectious Diseases

2023/4/15

Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave

Nature Medicine

2023/2

Comparison of model predictions of typhoid conjugate vaccine public health impact and cost-effectiveness

Vaccine

2023/1/23

Review of 2022 WHO guidelines on the control and elimination of schistosomiasis

2022/11/1

Contribution and quality of mathematical modeling evidence in World Health Organization guidelines: a systematic review

2022/6/1

COVID-19 Vaccination and Estimated Public Health Impact in California

JAMA Network Open

2022/4/1

Risk factor targeting for vaccine prioritization during the COVID-19 pandemic

Scientific Reports

2022/2/23

Predicting covid-19 outcomes

2022/2/17

WHO guideline on control and elimination of human schistosomiasis

2022

See List of Professors in Nathan Lo University(University of California, San Francisco)

Co-Authors

academic-engine